Abstract: This podcast presents an overview of new therapies on the horizon for breast cancer in terms of data presented at the European Society for Medical Oncology Congress, American Society of Clinical Oncology and the San Antonio Breast Cancer Symposium. In the adjuvant setting, results from the Microarray In Node negative Disease may Avoid ChemoTherapy (MINDACT) trial,SigueSigue leyendo «New horizon in breast cancer therapy: highlights from the European Society for Medical Oncology. Open Access.»
Archivo de etiqueta: ESMO
Heterogeneity of colon cancer: from bench to bedside. Open Access.
Abstract. The large bowel shows biomolecular, anatomical and bacterial changes that proceed from the proximal to the distal tract. These changes account for the different behaviour of colon cancers arising from the diverse sides of the colon–rectum as well as for the sensitivity to the therapy, including immunotherapy. The gut microbiota plays an important roleSigueSigue leyendo «Heterogeneity of colon cancer: from bench to bedside. Open Access.»
Dr Enrique Vicente Greco - Médico 